Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Articles
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (2)
  • 2025 (1)
  • 2024 (1)
  • 2023 (7)
  • 2022 (13)
  • 2021 (5)

Subject

  • Drug Trafficking (389)
  • Guilty Plea (136)
  • Arrests/Convictions - Major (131)
  • Synthetic drugs (107)
  • Guns/Weapons (95)
  • OCDETF/Task Force (73)
  • Prescription Drugs (36)
  • HIDTA (33)
  • Money Laundering (30)
  • Seizures (Drugs/Property) (30)
  • Diversion Division (26)
  • Task Forces/Task Force Officers (26)
  • Fake Pills (25)
  • Take Back Day (23)
  • Gangs (22)
  • Major Law Enforcement Operation (16)
  • Overdose (14)
  • Fentanyl Awareness (10)
  • Outreach/Drug Prevention (10)
  • Fentanyl Free America (7)
  • Extraditions (6)
  • Press Conferences (6)
  • Dark Web- Internet Trafficking (5)
  • International/Foreign Operations (5)
  • One Pill Can Kill (5)
  • Asset Forfeiture (4)
  • Prevention/Education - DEA websites GSAD, JTT etc (4)
  • Public and Media Affairs - also see Congressional Affairs (4)
  • Other (3)
  • Intelligence Division - Intelligence Products (2)
  • Intergovernmental Affairs (2)
  • Campaigns (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (29)

Drug Name

  • Oxycodone (7)
  • Opioids (5)
  • Amphetamines (2)
  • Hydromorphone (2)
  • Benzodiazepines (1)
  • Synthetic Opioids (1)

Field Division

  • Atlanta (12)
  • Caribbean (1)
  • Chicago (19)
  • Dallas (8)
  • El Paso (12)
  • Headquarters (10)
  • Houston (7)
  • Los Angeles (4)
  • Louisville (7)
  • Miami (17)
  • New England (5)
  • New Jersey (12)
  • New Orleans (4)
  • New York (22)
  • Omaha (3)
  • Philadelphia (1)
  • Phoenix (2)
  • Rocky Mountain (4)
  • San Diego (5)
  • San Francisco (9)
  • Seattle (9)
  • St. Louis (36)
  • Washington, DC (35)
Clear All Results
29 Results - Showing 1 to 10
PRESS RELEASE

Camden County Pharmacist Charged with Illegally Dispensing Oxycodone

CAMDEN, N.J. – Special Agent in Charge of the Drug Enforcement Administration's New Jersey Field Division Towanda R. Thorne-James and U.S. Attorney for the District of New Jersey Robert Frazer announced a Camden County pharmacist was charged in an indictment with unlawfully distributing oxycodone, and his wife was separately charged...
PRESS RELEASE

Nurse Practitioner in Jacksonville Pleads Guilty to Unlawful Distribution of Controlled Substances

Jacksonville, Fla. – Kenyatta Dacres (45, Jacksonville) has pleaded guilty to unlawful distribution of controlled substances. She faces a maximum penalty of 20 years in federal prison. A sentencing date has not yet been set. United States Attorney Gregory W. Kehoe made the announcement. According to court documents, Dacres was...
PRESS RELEASE

California Couple Sentenced to Prison for Mail Order Drug Trafficking

MIAMI – A federal district judge in Ft. Pierce sentenced a husband and wife to federal prison yesterday for working with a foreign drug trafficking organization to distribute methamphetamine, opioids, and other controlled drugs purchased by customers from an online pharmacy. U.S. District Judge Aileen M. Cannon sentenced Vanessa Vanly...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
PRESS RELEASE

Passaic County Doctor Charged in Conspiracy to Distribute Opioids

NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...
PRESS RELEASE

Toms River Woman Charged with Unauthorized Practice of Medicine, Forgery, Health Care Claims Fraud, and Distribution of a Controlled Dangerous Substance

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and Ocean County Prosecutor Bradley D. Billhimer announced that on July 25, 2023, Maria F. Macburnie, aka Marife L. Macburnie, 62, of Toms River, was charged with Practicing Medicine by an Unlicensed...
PRESS RELEASE

Jury Convicts Pain Clinic Doctor of Unlawful Drug Distribution, Money Laundering, and Filing a False Tax Return

TAMPA , F la. – United States Attorney Roger B. Handberg announced that a federal jury found Dr. Qing McGaha guilty of 14 counts of unlawful drug distribution, four (4) counts of money laundering, and one (1) count of filing a false tax return. McGaha faces a maximum penalty of...
PRESS RELEASE

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances

PENSACOLA, Fla. – Dr. George Barrio, a pain management physician who formerly practiced medicine at the NeuroMedical Institute in Panama City, agreed to pay $225,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients. The settlement was announced by Jason R. Coody, United States Attorney...
PRESS RELEASE

Physician Agrees to $190,731 Settlement Relating to Controlled Substances Act Claims

PENSACOLA, Fla. – Timothy Ramsden, of Panama City, Florida, practicing at The Anti-Aging Clinic of Northwest Florida, settled potential violations of the Controlled Substances Act by agreeing to pay a fine of $190,731 and surrendering his Drug Enforcement Administration (DEA) registration for Schedule II and IIN controlled substances for a...
PRESS RELEASE

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former office manager of a New Jersey medical practice admitted conspiring with the doctor who owned the...

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster